Alkermes PLC (ALKS)
23.86
+0.10
(+0.40%)
USD |
NASDAQ |
Apr 19, 16:00
23.86
0.00 (0.00%)
After-Hours: 20:00
Alkermes SG&A Expense (Quarterly): 140.57M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 140.57M |
September 30, 2023 | 169.45M |
June 30, 2023 | 205.26M |
March 31, 2023 | 174.48M |
December 31, 2022 | 142.54M |
September 30, 2022 | 152.78M |
June 30, 2022 | 150.38M |
March 31, 2022 | 145.05M |
December 31, 2021 | 149.04M |
September 30, 2021 | 136.21M |
June 30, 2021 | 139.19M |
March 31, 2021 | 125.17M |
December 31, 2020 | 145.78M |
September 30, 2020 | 127.65M |
June 30, 2020 | 132.02M |
March 31, 2020 | 133.37M |
December 31, 2019 | 154.45M |
September 30, 2019 | 148.70M |
June 30, 2019 | 155.08M |
March 31, 2019 | 141.22M |
December 31, 2018 | 141.23M |
September 30, 2018 | 128.78M |
June 30, 2018 | 138.26M |
March 31, 2018 | 118.15M |
December 31, 2017 | 110.90M |
Date | Value |
---|---|
September 30, 2017 | 99.63M |
June 30, 2017 | 108.95M |
March 31, 2017 | 102.10M |
December 31, 2016 | 97.14M |
September 30, 2016 | 91.14M |
June 30, 2016 | 96.12M |
March 31, 2016 | 89.72M |
December 31, 2015 | 87.47M |
September 30, 2015 | 89.50M |
June 30, 2015 | 71.54M |
March 31, 2015 | 63.05M |
December 31, 2014 | 54.80M |
September 30, 2014 | 51.89M |
June 30, 2014 | 50.66M |
March 31, 2014 | 42.55M |
September 30, 2013 | 39.45M |
June 30, 2013 | 32.93M |
March 31, 2013 | 34.68M |
December 31, 2012 | 29.87M |
September 30, 2012 | 31.43M |
June 30, 2012 | 29.78M |
March 31, 2012 | 34.43M |
December 31, 2011 | 35.47M |
September 30, 2011 | 36.23M |
June 30, 2011 | 31.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
125.17M
Minimum
Mar 2021
205.26M
Maximum
Jun 2023
148.80M
Average
145.78M
Median
Dec 2020
SG&A Expense (Quarterly) Benchmarks
Endo International PLC | 140.43M |
Jazz Pharmaceuticals PLC | 396.03M |
Medtronic PLC | 2.673B |
Perrigo Co PLC | 306.80M |
Iterum Therapeutics PLC | 1.687M |